Literature DB >> 32432749

Linc00707 promotes cell proliferation, invasion, and migration via the miR-30c/CTHRC1 regulatory loop in breast cancer.

R-X Yuan1, D Bao, Y Zhang.   

Abstract

OBJECTIVE: Breast cancer (BC) is the most common malignant tumor in women. We aimed at investigating the function of long non-coding RNA LINC00707 in BC and the potential mechanism. PATIENTS AND METHODS: The expression level of linc00707 was determined using the quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) in BC tissues and cell lines. The Cell Counting Kit-8 (CCK-8) and colony formation assays were performed to detect the potential influence of LINC0070 on the proliferation ability of the BC cells. Also, the invasion and migration abilities were assessed by the transwell assay. Furthermore, with the bioinformatic analysis and the Dual-Luciferase Reporter Gene Assay, we analyzed the interaction in LINC00707/miR-30c/CTHRC1 regulatory loop. The regulatory effects of LINC00707/miR-30c/CTHRC1 on BC were finally determined.
RESULTS: LINC00707 was significantly upregulated in BC tissues and cell lines. The knockdown of LINC00707 inhibited proliferation, invasion, and migration in MDA-MB-231 cells, while the overexpression of LINC00707 achieved the opposite results in MDA-MB-468 cells. LINC00707, acting as a competing endogenous RNA (ceRNA), could sponge miR-30c to upregulate CTHRC1, thus promoting BC progression.
CONCLUSIONS: LINC00707 was highly expressed in BC tissues and cells. It promoted cell proliferation, invasion, and migration via miR-30c/CTHRC1 regulatory loop. This might provide a novel target for the diagnosis, treatment, and prognosis for BC.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32432749     DOI: 10.26355/eurrev_202005_21175

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  7 in total

1.  [Effects of RNA interference of CTHRC1 on proliferation and apoptosis of thyroid papillary cancer TCP-1 cells in vitro].

Authors:  Z Tang; X Ding; S Qin; C Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-04-20

2.  HNRNPD interacts with ZHX2 regulating the vasculogenic mimicry formation of glioma cells via linc00707/miR-651-3p/SP2 axis.

Authors:  Sifei Yu; Xuelei Ruan; Xiaobai Liu; Fangfang Zhang; Di Wang; Yunhui Liu; Chunqing Yang; Lianqi Shao; Qianshuo Liu; Lu Zhu; Yang Lin; Yixue Xue
Journal:  Cell Death Dis       Date:  2021-02-04       Impact factor: 8.469

Review 3.  Review of LINC00707: A Novel LncRNA and Promising Biomarker for Human Diseases.

Authors:  Qinfan Yao; Zheng Li; Dajin Chen
Journal:  Front Cell Dev Biol       Date:  2022-01-26

4.  LINC00707 Promotes Cell Proliferation in Cervical Cancer via the miR-374c-5p/SDC4 Axis.

Authors:  Fang Fang; Chunfeng Guo; Weinan Zheng; Qingyang Li
Journal:  Biomed Res Int       Date:  2022-07-28       Impact factor: 3.246

5.  miR-30c plays diagnostic and prognostic roles and mediates epithelial-mesenchymal transition (EMT) and proliferation of gliomas by affecting Notch1.

Authors:  Mengkao Li; Wenzhi Liu; Jian Li; Hong Zhang; Jin Xu
Journal:  Sci Rep       Date:  2022-09-30       Impact factor: 4.996

6.  Identification of microRNA hsa-miR-30c-5p as an inhibitory factor in the progression of hepatocellular carcinoma and investigation of its regulatory network via comprehensive analysis.

Authors:  Shangshang Hu; Jinyan Zhang; Xiaoyu Fang; Guoqing Guo; Jing Dai; Zhiyong Sheng; Dongdong Li; Jiasheng Chen; Li Zhang; Chuanmiao Liu; Yu Gao
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

7.  LINC00707 Regulates miR-382-5p/VEGFA Pathway to Enhance Cervical Cancer Progression.

Authors:  Hua Guo; Jing Li; Furong Fan; Ping Zhou
Journal:  J Immunol Res       Date:  2021-06-29       Impact factor: 4.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.